Vaginal Estrogen Therapy Is Associated with Increased Lactobacillus in the Urine of Post-Menopausal Women with Overactive Bladder Symptoms

Overactive BladderMenopause

Does vaginal estriol make urodynamic changes in women with overactive bladder syndrome and genitourinary syndrome of menopause

Eur J Obstet Gynecol Reprod Biol.

Matarazzo MG, Caruso S, Giunta G, Valenti G, Sarpietro G, Cianci A

doi: 10.1016/j.ejogrb.2018.01.002.

Menopause

Endometrial safety of low-dose vaginal estrogens in menopausal women: a systematic evidence review

Menopause.

Constantine GD, Graham S, Lapane K, Ohleth K, Bernick B, Liu J, Mirkin S

doi: 10.1097/GME.

Menopause

Vascular dysfunction across the stages of the menopausal transition is associated with menopausal symptoms and quality of life

Menopause.

Hildreth KL, Ozemek C, Kohrt WM, Blatchford PJ, Moreau KL

Overactive BladderUrinary Incontinence

Retrospective analysis in 46 women with vulvovaginal atrophy treated with ospemifene for 12 weeks: improvement in overactive bladder symptoms

Gynecol Endocrinol.

Schiavi MC, Zullo MA, Faiano P, D'Oria O, Prata G, Colagiovanni V, Giannini A, Di Tucci C, Perniola G, Di Donato V, Monti M, Muzii L, Benedetti Panici P

doi: 10.1080/

Overactive BladderUrinary IncontinenceUrinary Tract Infections (UTI)

Overactive bladder symptoms after midurethral sling surgery in women: Risk factors and management

Neurourol Urodyn.

Marcelissen T, Van Kerrebroeck P

doi: 10.1002/nau.23328.

Menopause

The British Menopause Society consensus statement on the management of estrogen deficiency symptoms, arthralgia and menopause diagnosis in women treated for early breast cancer

Post Reprod Health.

Marsden J, Marsh M, Rigg A; British Menopause Society

doi: 10.1177/2053369118824920.

Overactive Bladder

Beyond the bladder: poor sleep in women with overactive bladder syndrome

Am J Obstet Gynecol.

Savoie MB, Lee KA, Subak LL, Hernandez C, Schembri M, Fung CH, Grady D, Huang AJ

doi: 10.1016/j.ajog.2019.12.005.

Menopause

Genetic variants associated with earlier age at menopause increase the risk of cardiovascular events in women

Menopause.

Sarnowski C, Kavousi M, Isaacs S, Demerath EW, Broer L, Muka T, Franco OH, Ikram MA, Uitterlinden A, Franceschini N, Lunetta KL, Murabito JM

doi: 10.1097/

Overactive Bladder

Effectiveness of Combined Behavioral and Drug Therapy for Overactive Bladder Symptoms in Men: A Randomized Clinical Trial

JAMA Intern Med.

Burgio KL, Kraus SR, Johnson TM 2nd, Markland AD, Vaughan CP, Li P, Redden DT, Goode PS

doi: 10.1001/jamainternmed.2019.6398.

Related content

Does vaginal estriol make urodynamic changes in women with overactive bladder syndrome and genitourinary syndrome of menopause

Endometrial safety of low-dose vaginal estrogens in menopausal women: a systematic evidence review

Vascular dysfunction across the stages of the menopausal transition is associated with menopausal symptoms and quality of life

Retrospective analysis in 46 women with vulvovaginal atrophy treated with ospemifene for 12 weeks: improvement in overactive bladder symptoms

Overactive bladder symptoms after midurethral sling surgery in women: Risk factors and management

The British Menopause Society consensus statement on the management of estrogen deficiency symptoms, arthralgia and menopause diagnosis in women treated for early breast cancer

Beyond the bladder: poor sleep in women with overactive bladder syndrome

Genetic variants associated with earlier age at menopause increase the risk of cardiovascular events in women

Effectiveness of Combined Behavioral and Drug Therapy for Overactive Bladder Symptoms in Men: A Randomized Clinical Trial